The cost of complex therapies is soaring, and the challenge is to deliver access to these medications in the most cost-effective and clinically appropriate site of service.
Mike Ellis, BSPharm
Advertisement
Articles by Mike Ellis, BSPharm
As part of its pharmacist-driven ConnectedCare Oral Oncology Program, Walgreens Specialty Pharmacy recently conducted a unique 3-month monitored-dispense pilot program, which reflects continued innovation, additional cost savings, and improved health care system communication.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
Clots, Catheters, and Clinical Pearls: Pulmonary Embolism Updates for Practicing Pharmacists
2
Cyclosporiasis on the Rise in the United States, Exceeding 450 Cases
3
Medicare's New GLP-1 Bridge Program: What Pharmacists Need to Know Before Dispensing
4
GLP-1 RAs Linked to Lower Mortality, Amputation Risk in Patients With PAD and Type 2 Diabetes
5